The observation that nuclear p50 NF-κB controls DC survival, tolerogenic as well as immunogenic functions indicates that p50 is a major determinant of both innate and adaptive immune responses and underpins its relevance in diseases characterized by aberrant immune responses, including infection, transplantation and cancer. Here, NFKB1 is linked to cancer.